Small Diagnostics Company Aims To Change Lab Field Testing (OTC:BMGP)

Written by M.E.Garza

Wednesday, 14 October 2009 00:00

Diagnostics, the technologies and tools used to identify diseases and conditions in patients make up the second-largest portion of the biotechnology industry. A new technology, originally developed with funding from the Department of Homeland Security, allows laboratories to perform far more tests in the same amount of time it takes to do a single test and is designed to detect the actual virus and viral load in any body fluid.

BMGP Receives a Financing Commitment
to Speed Development of Malaria Testing

BMGP Enters into Agreement
with One of China's Largest Dairies

BMGP Appoints Rothschild
as Special Adviser to Board

Biomagnetics Diagnostics Corp. (OTC:BMGP) is a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing.

Several key developments have put this company on our radar screen including the fact that there is significant demand throughout the world for advanced field deployable testing technologies.

The company has made it one of their goals to provide innovative products to meet this demand and to deploy their testing equipment and technologies in the field as well as in the clinical setting for a wide variety of pathogens.

Joe Noel, who introduced many investors to BioElectronics Corporation, tells us about this intriguing penny stock play within the diagnostics space.

A special, in-depth audio interview can be heard below (click on the player under the image):

BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section

Add this page to your favorite Social Bookmarking websites